 |
|
Prevalence of Vitamin D Insufficiency in Patients With Parkinson Disease and Alzheimer Disease
Marian L. Evatt, MD, MS;
Mahlon R. DeLong, MD;
Natasha Khazai, MD;
Ami Rosen, MS;
Shirley Triche, RN;
Vin Tangpricha, MD, PhD
Arch Neurol. 2008;65(10):1348-1352.
Background A role for vitamin D deficiency in Parkinson disease (PD) has recently been proposed.
Objective To compare the prevalence of vitamin D deficiency in a research database cohort of patients with PD with the prevalence in age-matched healthy controls and patients with Alzheimer disease (AD).
Design Survey study and blinded comparison of plasma 25-hydroxyvitamin D (25[OH]D) concentrations of stored samples in a clinical research database at Emory University School of Medicine.
Setting Referral center (PD and AD patients), primary care clinics, and community setting (controls).
Participants Participants were recruited into the study between May 1992 and March 2007. Every fifth consecutively enrolled PD patient was selected from the clinical research database. Unrelated AD (n = 97) and control (n = 99) participants were randomly selected from the database after matching for age, sex, race, APOE genotype, and geographic location.
Main Outcome Measures Prevalence of suboptimal vitamin D and mean 25(OH)D concentrations.
Results Significantly more patients with PD (55%) had insufficient vitamin D than did controls (36%) or patients with AD (41%; P = .02,  2test). The mean (SD) 25(OH)D concentration in the PD cohort was significantly lower than in the AD and control cohorts (31.9 [13.6] ng/mL vs 34.8 [15.4] ng/mL and 37.0 [14.5] ng/mL, respectively; P = .03).
Conclusions This report of 25(OH)D concentrations in a predominantly white PD cohort demonstrates a significantly higher prevalence of hypovitaminosis in PD vs both healthy controls and patients with AD. These data support a possible role of vitamin D insufficiency in PD. Further studies are needed to determine the factors contributing to these differences and elucidate the potential role of vitamin D in pathogenesis and clinical course of PD.
Author Affiliations: Division of Movement Disorders, Department of Neurology (Drs Evatt and DeLong and Mss Rosen and Triche), and Division of Endocrinology, Diabetes, and Lipids, Department of Medicine (Drs Khazai and Tangpricha), Emory University School of Medicine, Atlanta, Georgia.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2008;65(10):1278-1280.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Beneficial Role of Vitamin D in Alzheimer's Disease
Lu'o'ng and Nguy{ecirctilde}n
AM J ALZHEIMERS DIS OTHER DEMEN 2011;26:511-520.
ABSTRACT
Outdoor work and risk for Parkinson's disease: a population-based case-control study
Kenborg et al.
Occup. Environ. Med. 2011;68:273-278.
ABSTRACT
| FULL TEXT
High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease
Evatt et al.
Arch Neurol 2011;68:314-319.
ABSTRACT
| FULL TEXT
Vitamin D and Cognitive Impairment in the Elderly U.S. Population
Llewellyn et al.
J Gerontol A Biol Sci Med Sci 2011;66A:59-65.
ABSTRACT
| FULL TEXT
Vitamin D and Cognitive Decline in Elderly Persons: Further Details
Evatt
Arch Neurol 2010;67:1513-1515.
FULL TEXT
Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition
Kones
Nutr Clin Pract 2010;25:371-389.
ABSTRACT
| FULL TEXT
Beyond Vitamin Status: Is There a Role for Vitamin D in Parkinson Disease?
Evatt
Arch Neurol 2010;67:795-797.
FULL TEXT
Serum Vitamin D and the Risk of Parkinson Disease
Knekt et al.
Arch Neurol 2010;67:808-811.
ABSTRACT
| FULL TEXT
FAMILY HISTORY OF MELANOMA AND PARKINSON DISEASE RISK
Mascitelli et al.
Neurology 2010;74:1397-1397.
FULL TEXT
New Techniques in Transcription Research Extend Our Understanding of the Molecular Actions of the Vitamin D Hormone
Pike et al.
IBMS BoneKEy 2009;6:169-180.
ABSTRACT
| FULL TEXT
|
